Normal lymphoscintigraphy values to unravel breast cancer lymphoedema

  • Research type

    Research Study

  • Full title

    Establishing normal lymphoscintigraphy values to unravel breast cancer related lymphoedema

  • IRAS ID

    225017

  • Contact name

    Petros Charalampoudis

  • Contact email

    Petros.Charalampoudis@gstt.nhs.uk

  • Sponsor organisation

    Kings College London

  • Duration of Study in the UK

    0 years, 11 months, 30 days

  • Research summary

    Breast cancer related lymphoedema is a swelling of the arm that presents following axillary lymph node surgery. It is an irreversible side effect of treatment, that affects 1 out of 4 patients undergoing axillary clearance and 1 out of 20 undergoing sentinel lymph node biopsy. It is associated with significant physical, functional, psychological and social morbidity requiring lifelong management.

    Despite its prevalence, breast cancer related lymphoedema remains a poorly understood process and it remains unclear why some patients develop the condition and others do not.

    We recently suggested that lymphatic weakness (‘latent lymphoedema’) may predispose women to breast cancer related lymphoedema. Studying lower limbs of women more than 3 years post-axillary treatment, we found that lymphatic function was decreased in women who have developed breast cancer related lymphoedema compared with those who had not.

    Lymphoscintigraphy with subcutaneous Tc-99m-nanocolloid is currently the preferred method for assessing lymphatic function in limb swelling of unknown cause. Despite its widespread use, lymphoscintigraphic protocols vary greatly both in clinical practice and in the scientific literature. Some include exercise as a ‘stress’ for lymphatics; the timing of image capture also varies across centres. This renders lymphoscintigraphic results difficult to compare and their accuracy questionable.

    We recently described a novel approach of lymphoscintigraphic quantification which was found to improve the detection rate of abnormal lymphatic function in clinically swollen limbs by over 30%.
    This study was however conducted in a cohort of patients with clinically abnormal limbs, and therefore normal values remain to be established.

    Once an accurate range of normal is identified, this technique could provide the opportunity to assess lymphatic function and potentially identify latent lymphoedema in breast cancer patients prior to the onset of swelling.

    We are planning to conduct this study in healthy volunteers to help us understand the normal standards of lymph drainage in the healthy lower limb.

  • REC name

    London - Chelsea Research Ethics Committee

  • REC reference

    17/LO/0624

  • Date of REC Opinion

    21 Apr 2017

  • REC opinion

    Favourable Opinion